Objectives: To optimize protamine titration for heparin antagonization after weaning from cardiopulmonary bypass (CPB).
Design: A prospective, observational trial.
Setting: Single-center, non-university teaching hospital.
Participants: Forty patients presenting for elective on-pump coronary artery bypass grafting with or without single valve surgery.
Interventions: At the end of CPB, the residual amount of heparin in the patient was estimated using a Bull-curve. The total protamine dose was calculated as 1 unit of protamine for 1 unit of heparin. Protamine was administered as 5 aliquots containing 20% of the total protamine dose each, with 2-min intervals.
Measurements And Main Results: Activated Clotting Time (ACT) values were measured 2 min after administration of each aliquot. ROTEM(®)-analysis was performed after the full dose of protamine had been administered. After 60% of the total protamine dose had been administered, ACT values were normalized in 86.5% of patients. After the complete dose of protamine had been administered, 61.1% of patients displayed signs of protamine overdose on ROTEM(®)-analysis.
Conclusions: In patients who present for on-pump coronary artery bypass grafting with or without single valve surgery, a 0.6-to-1 ratio of protamine-to-heparin to antagonize heparin may be sufficient and beneficial for patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/02676591221144702 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Signalment, clinicopathological findings, management practices and comorbidities in cats with diabetes mellitus in Germany: cross-sectional study of 144 cases.
J Feline Med Surg
January 2025
Clinic for Small Animals (Internal Medicine, Clinical Pathology and Clinical Pathophysiology), Justus-Liebig-University Giessen, Germany.
Objectives: The aim of this study was to describe signalment, clinicopathological findings, management practices and the occurrence of comorbidities in feline diabetes mellitus (DM) in Germany.
Methods: This was a cross-sectional study using questionnaires and laboratory submissions to a commercial laboratory, Antech Lab Germany, between May 2021 and July 2022. Inclusion criteria were diagnosis of DM by the attending veterinarian and submission of a completed questionnaire besides blood samples.
Heparin rebound in patients undergoing off-pump coronary artery bypass grafting surgery: a single-center retrospective study.
J Cardiothorac Surg
January 2025
Department of Anesthesiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 167, Beilishi Road, Xicheng District, China.
Background: Heparin, an anticoagulant used in cardiac surgery, can result in heparin rebound (HR), where it returns postoperatively despite being neutralized with protamine. This study was designed to investigate the prevalence of HR in patients undergoing off-pump coronary artery bypass grafting (OPCAB) and evaluate the impact of HR on their short-term outcomes.
Methods: HR was defined by a 10% increase in activated coagulation time (ACT) following two hours of heparin neutralization with protamine, bleeding over 200 mL/h, and abnormal laboratory coagulation examination results.
4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery.
Blood Coagul Fibrinolysis
November 2024
Department of Anesthesiology, Rush University Medical Center, Chicago, Illinois, USA.
Article Synopsis
- The study aimed to compare the occurrence of thromboembolic complications between two treatments, 4-factor prothrombin complex concentrate (4F-PCC) and factor VIII inhibitor bypassing activity (FEIBA), during cardiac surgery.
- Data was retrospectively analyzed from a university hospital involving patients who underwent cardiac procedures with cardiopulmonary bypass, focusing on various medical outcomes.
- Results indicated no significant difference in thromboembolic events, acute kidney injuries, or hospital stays between the two treatment groups, although variations in blood product usage were noted.
Impact of Supplemented Nutrition on Semen Quality, Epigenetic-Related Gene Expression, and Oxidative Status in Boars.
Animals (Basel)
November 2024
Department of Reproduction, Fertility and Artificial Insemination, Faculty of Veterinary Medicine, University of Belgrade, 11000 Belgrade, Serbia.
This study investigates the impact of nutritional supplementation on semen quality, epigenetic-related gene expression, and oxidative status in boars. Thirty boars were divided into a control group and a treatment group receiving Espermaplus (a supplement containing various vitamins, amino acids, omega-3 fatty acids, and trace elements with antioxidant properties). The experiment was performed for 12 weeks.
View Article and Find Full Text PDFThe impact of antioxidants on antioxidant capacity, DNA fragmentation, and chromatin quality in subfertile men: a randomized clinical trial study.
Rev Assoc Med Bras (1992)
November 2024
Ondokuz Mayıs University, Faculty of Medicine, Department of Medical Biology - Samsun, Turkey.
Objective: This randomized clinical trial study aims to investigate the effects of antioxidant food supplementation on the total antioxidant capacity of seminal plasma, sperm DNA fragmentation, sperm chromatin quality, and semen parameters.
Methods: In this study, a total of 48 subfertile men with moderate physical activity were included. Group 1 was recommended to use the antioxidant supplements, while antioxidant food supplements were not given to Group 2.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!